Zydelig Interactions
There are 871 drugs known to interact with Zydelig (idelalisib), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 230 are major, 624 are moderate, and 17 are minor.
- View all 871 medications that may interact with Zydelig
- View Zydelig alcohol/food interactions (1)
- View Zydelig disease interactions (7)
Most frequently checked interactions
View interaction reports for Zydelig (idelalisib) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adempas (riociguat)
- Adriamycin RDF (doxorubicin)
- Alimta (pemetrexed)
- allopurinol
- Aptivus (tipranavir)
- aspirin
- atenolol
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Baraclude (entecavir)
- Bexxar (iodine i 131 tositumomab)
- bleomycin
- Blincyto (blinatumomab)
- Crixivan (indinavir)
- Entyvio (vedolizumab)
- Farydak (panobinostat)
- Isentress (raltegravir)
- Juxtapid (lomitapide)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- omeprazole
- Pomalyst (pomalidomide)
- Prolia (denosumab)
- Revlimid (lenalidomide)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Tecentriq (atezolizumab)
- Truvada (emtricitabine / tenofovir disoproxil)
- Tylenol (acetaminophen)
Zydelig alcohol/food interactions
There is 1 alcohol/food interaction with Zydelig (idelalisib).
Zydelig disease interactions
There are 7 disease interactions with Zydelig (idelalisib) which include:
- colitis
- dermatologic toxicities
- hepatic impairment
- infections
- intestinal perforation
- neutropenia
- lung toxicity
Report options
QR code containing a link to this page
More about Zydelig (idelalisib)
- Zydelig consumer information
- Compare alternatives
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: PI3K inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
